How Biotechs Shape CDMO Capabilities
By Erin Harris, Editor-In-Chief, Cell & Gene
Follow Me On Twitter @ErinHarris_1
What You’re About to Watch
Vibalogics is headquartered in Germany and operates a fully functional CDMO facility, and the company is building a second facility in Boston. CEO Tom Hochuli and President and Managing Director Dr. Stefan Beyer answer my questions about how biotechs have helped shape the new facility’s capabilities.
Why You Should Care
Hochuli and Beyer address the current capacity of viral vectors and how the CDMO will help biotechs achieve scalability.
This website uses cookies to ensure you get the best experience on our website. Learn more